NP Life Sciences Health Industry Group Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $234.9K | $242.9K |
| FY2020 | — | $103.8K | $118.6K |
| FY2021 | — | $38.2K | $28.0K |
| FY2022 | — | $19.3K | $121.9K |
| FY2023 | — | $16.4K | $70.6K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $234.9K | $242.9K |
| FY2020 | — | $103.8K | $118.6K |
| FY2021 | — | $38.2K | $28.0K |
| FY2022 | — | $19.3K | $121.9K |
| FY2023 | — | $16.4K | $70.6K |